1 |
Characterisation of blood dendritic cells in patients with cancer /Pinzon-Charry, Alberto. January 2005 (has links) (PDF)
Thesis (Ph.D.) - University of Queensland, 2005. / Includes bibliography.
|
2 |
Genomic variation and cell tropism of bovine diarrhoea virusDesport, Moira January 2000 (has links)
No description available.
|
3 |
Investigations into the mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immune suppression: effects on dendritic cell phenotype and functionVorderstrasse, Beth A. 07 June 2000 (has links)
T cell-dependent immune responses are highly sensitive to suppression by
exposure to the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD), yet direct effects of TCDD on T cells have been difficult to demonstrate.
Because the activation of naive T cells is initiated by dendritic cells (DC), the studies
presented in this dissertation were designed to test the hypothesis that TCDD affects
these antigen-presenting cells in a manner which ultimately results in suppressed T cell
activation. The expression of numerous cell surface proteins known to be important
in signaling T cells to proliferate and differentiate was evaluated on splenic DC from
C57B1/6 and Balb/c mice. The production of IL-12 and the ability of DC to activate
allogeneic and antigen-specific T cells were also tested. Contrary to expectation,
exposure to TCDD resulted in enhanced expression of several accessory molecules
including B7-2, CD40, ICAM-1, CD24 and the major histocompatibility complex
(MHCII). In contrast, expression of LFA-1 was significantly decreased on DC from
TCDD-treated mice. These effects were dose-dependent, persisted for at least 14 days,
and did not occur in aryl hydrocarbon receptor (AhR)-deficient mice. Interestingly,
TCDD treatment also decreased the numbers of DC recovered from the spleen by day
7 following exposure in C57B1/6 mice and by day 3 in Balb/c animals. When T cells
were cultured with DC from TCDD-treated mice, the proliferative response of the T
cells and the production of IL-2, IL-4, and IFN-�� was not suppressed but instead
tended to be increased. DC production of IL-12 was also enhanced. Furthermore,
TCDD did not interfere with the ability of DC to internalize latex beads or to activate
antigen-specific T cells, suggesting that uptake and processing of antigen by DC is not
impaired by TCDD. AhR message was detected in splenic DC and AhR protein was
found in two DC cell lines, indicating that DC may be directly affected by TCDD.
Taken together, these results suggest that TCDD provides an activation stimulus to DC
and may lead to their premature deletion. The relationship between these effects and
TCDD-induced immune suppression remains to be determined. / Graduation date: 2001
|
4 |
Role of blood myeloid and plasmacytoid dendritic cells in chronic renal failure and kidney transplantation.Lim, Wai Hon January 2006 (has links)
Title page, table of contents and abstract only. The complete thesis in print form is available from the University of Adelaide Library. / This study demonstrates that dendritic cell (DC) defects are common in chronic renal failure, dialysis and transplant recipients and this is likely to contribute to their underlying immune deficiency and high risk of infections and malignancies. Simple and effective clinical strategies (e.g. improvement in dialysis efficiency) which aim to correct DC deficiencies could potentially lead to direct improvement in patient outcome. / http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1277089 / Thesis (Ph.D.) -- University of Adelaide, School of Medicine, 2006
|
5 |
Role of blood myeloid and plasmacytoid dendritic cells in chronic renal failure and kidney transplantation.Lim, Wai Hon January 2006 (has links)
Title page, table of contents and abstract only. The complete thesis in print form is available from the University of Adelaide Library. / This study demonstrates that dendritic cell (DC) defects are common in chronic renal failure, dialysis and transplant recipients and this is likely to contribute to their underlying immune deficiency and high risk of infections and malignancies. Simple and effective clinical strategies (e.g. improvement in dialysis efficiency) which aim to correct DC deficiencies could potentially lead to direct improvement in patient outcome. / http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1277089 / Thesis (Ph.D.) -- University of Adelaide, School of Medicine, 2006
|
6 |
The HER2/neu oncoprotein and dendritic cells in immunity against tumors /Rongcun, Yang, January 1900 (has links)
Diss. (sammanfattning) Stockholm : Karol. inst. / Härtill 5 uppsatser.
|
7 |
Studies on dendritic cells in multiple sclerosis and experimental allergic encephalomyelitis /Huang, Yu-Min, January 1900 (has links)
Diss. (sammanfattning) Stockholm : Karol. inst. / Härtill 5 uppsatser.
|
8 |
Study of calreticulin mediated NY-ESO-1 immunogenicity in human dendritic cells /Zeng, Chenjie. January 2008 (has links)
Thesis (M.Phil.)--Hong Kong University of Science and Technology, 2008. / Includes bibliographical references (leaves 118-131). Also available in electronic version.
|
9 |
Human cytomegalovirus and dendritic cell interaction : role in immunosuppression and autoimmunity /Varani, Stefania, January 2005 (has links)
Diss. (sammanfattning) Stockholm : Karol. inst., 2005. / Härtill 5 uppsatser.
|
10 |
Role of FDCs and FDC activation in promoting humoral immunity including responses to T-dependent antigens in the absence of T cells /El Sayed, Rania Mohamed, January 2009 (has links)
Thesis (Ph. D.)--Virginia Commonwealth University, 2009. / Prepared for: Dept. of Microbiology and Immunology. Bibliography: leaves 213 - 235. Available online via the internet.
|
Page generated in 0.0741 seconds